PA
HCA icon

PharVision Advisers’s HCA Healthcare HCA Stock Holding History

PharVision Advisers’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-465
Closed -$217K – 341
2025
Q4 		$217K Sell
465
-14
-3% -$6.5K 0.11% 493
2025
Q3 		$204K Buy
+479
New +$186K 0.11% 500

Other funds holding HCA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PharVision Advisers's HCA Position: Q1 2026 in Review

PharVision Advisers sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 465 shares — an estimated $217K sold.

PharVision Advisers first reported a position in HCA in Q3 2025 and held it in 2 quarters. The position peaked at $217K in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • PharVision Advisers reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 465 HCA Healthcare shares in Q1 2026, an estimated $217K.
  • PharVision Advisers first reported a position in HCA Healthcare in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's HCA Healthcare position peaked at $217K in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.